Research & Facilities

R&D Strength

Suven Pharma has an in house team of highly qualified professionals to ensure customer satisfaction.

Suven Pharma provides state-of-the-art R&D facilities to handle challenging product development. Our core competency is the rapid transfer of technology from the lab to the commercialization level. We flourish in the development of new product processes in association with top global pharmaceutical and fine chemical companies.

Security / Confidentiality - Intellectual Property

Suven Pharmaceuticals Limited complies with and upholds global patent regulations. Through restricted access, you can ensure the security and confidentiality of client data. Client-confidential information is promptly delivered upon demand during the relationship or afterwards. The client's proprietary information shall remain the client's property.

Project Management

Each project's quality and timeliness are guaranteed by a project team who are governed by a project manager and a group of scientists.

The project manager serves as the client’s exclusive point of contact. Secured emails, regular teleconferences, videoconferences, and periodic reports make up the entirety of the communication process. On predetermined timelines, the project manager provides updates on the status and direction of the project. Suven Pharma provides a comprehensive project report upon the completion of the project. All documents and information deemed necessary shall be given to the client in accordance with the terms and circumstances of the contract with the customer.

Project Management

Each project's quality and timeliness are guaranteed by a project team who are governed by a project manager and a group of scientists.

The project manager serves as the client’s exclusive point of contact. Secured emails, regular teleconferences, videoconferences, and periodic reports make up the entirety of the communication process. On predetermined timelines, the project manager provides updates on the status and direction of the project. Suven Pharma provides a comprehensive project report upon the completion of the project. All documents and information deemed necessary shall be given to the client in accordance with the terms and circumstances of the contract with the customer.

Research

Our team goes above and beyond in providing innovative solutions that drive a MOLECULE from LAB-to-COMMERCIALIZATION. We align our Drug Development and Manufacturing Services capabilities to create long-term mutually beneficial relationships in bringing innovative medicines to the world.

Our services include Custom Synthesis, Process R&D, Scale Up, and CDMO for finished Contract Manufacturing of intermediates, APIs, and formulations.

At Suven Pharma, we are exploring new possibilities that will continue to enrich our business relations with global innovators.

Analytical Capabilities

HPLCs (UV,PDA,RI,ELSD)

UPLC

LC-MS

ICP- MS

GC (Head Space, FID & NPC)

FTIR

UV Spectrophotometer

Polarimeter

Polarographic Analyzer

Osmometer

Particle Size Analyzer

Dissolution Apparatus

Total Organic Carbon (TOC)

Ion Chromatography

Reaction Capabilities

Alkylation's
  • Acylation​
  • Amidation
  • Chiral alkylation
  • Condensation
  • Cyanation
  • Cyclo-condensation​
  • Formylations
  • Grignard reactions
  • Halogenation Using bromine, chlorine, POCl3 etc.,​
  • Heck Arylation
Chiral Chemistry
  • Asymmetric Synthesis
  • Carbohydrates
  • Grignard Reaction
  • Horner-Emmons Wadsworth Reaction
  • Organoborane Catalytic
  • Asymmetric  Reduction
  • Heterogeneous Catalytic Reduction
  • Reaction at -70° to +200°
  • High Vacuum Distillation​

Hydrogenation using pd/c, Pt/c, Rh/c and Raney-Ni​

Metallation – MeLi / n-BuLi / LDA/HMDS​

Mitsunobu Reaction​

Oxidation – Jones, Swern, KMnO4, NaIO4, Nitric acid​

Reductions – Catalytic, Metal hydrides, High pressure, Metal catalysed, Birch reductions, Diborane, LAH, DIBAL-H, Catalytic, NaCNBH3 and vitride.​

Suzuki Coupling​

Asymmetric synthesis​

Enzymatic resolution​

Epoxidation reaction​

Chiral separation by resolution​

Chiral Technology Products

SUFINAMIDE CHIRAL TECHNOLOGY VIZ.,
  • Sulfinamide & t-Butylsulfinamide (R&S)​
  • p-Toluenesulfinamide (R&S )​
  • P-Toluenemethane sulfoxide (R&S)​
  • 2.4.6 trimethylphenylsulfinamide (R&S)
  • 3-Hydroxytetrahydrofuran (R&S)​
  • 3-hydroxypyrrolidine (R&S)​
  • 3-Aminopyrrolidine (R&S)​
  • 3-Cyanopyrrolidine (R&S)​
  • 3-Carboxypyrrolidine (R&S)​
  • 3-Hydroxy-N-benzylpyrroline (R&S D)​
  • 3-Aminotetrahydrofuran (R&S)​
  • Pyrrolidine-3-carboxylic acid (R&S)
SUGAR DERVATIVES
  • 4-Hydroxy-2-pyrrolidone (R&S)​
  • 2-Hydroxy-1,4-diol (R&S)

Products Familiarity

Products Familiarity
  • Indole compounds​
  • Pyrimidine compounds​
  • Pyridine compounds​
  • Pyrazole compounds​
  • Pyrazine compounds​
  • Indazole compounds​
  • Imidazole compounds​
  • Thiazole compounds​
  • Isoquinoline compounds​
  • Pyrrolidine compounds​
  • Piperazine compounds​
  • Piperidine compounds​​
  • Pyridazine compounds
  • 1,2,3-Triazole compounds​
  • 1,2,4-triazole compounds​
  • Tetrazole compounds​
  • Sugar derivatives​
  • Ribose derived compounds​
  • Phosphoramidite​
  • Nucleoside Phosphoramidites​
  • Benzothiazole compounds​
  • Benziminazole compounds​
  • Benzofuran compounds​
  • Pyrrole compounds
Science and Innovation are the foundation of

Suven Technology Strengths

Cyanation and MalonatesCyanation and Malonates

Multi-Step Organic Synthesis

Friedel-Crafts Reactions

Nitrations

High Temperature [260°]

Low Temperature [-70°]

Heterocyclic Compounds

Carbohydrate Chemistry

Grignard Reaction

High Pressure Reactions [25 Bar]

Haloenation [Br2,POCl3,PCl3,l2,Cl2,NBS,Non-HF fluorination]

Chiral Building Blocks/Asymmetric Synthesis

Liquid Ammonia, Alkali Metals and Organometallics

N-Butyl Lithium

Reduction-Catalytic [Ni, Pd, Rh, Ru & NaBH4]

Oxidation Reactions

Facilities

Reactor Volume with type of Reaction Capacities as on June, 2022

Reaction Type

MOC

Cu.M

SS316

753

Glass Lined

631

Others

11

Total volume

1395

Reactor Capacity

Cu.M

Suryapet

266

Jeedimetla

28

Pashamylaram

375

JNPC-Vizag

726

Total volume

1395

Reactor Capacities (Cu.M.) by MOC

SS316

Glass Lined

Others

Reactor Volume - 1395 Cu.M.

Suryapet

Jeedimetla

Pashamylaram

JNPC-Vizag

JNPC - Vizag

Reactor Volume -

726 / 1395 m3

Suven Pharmaceuticals Limited, Plot No’s: 65 to 67, JN Pharma City, Thanam(V), Parawada Mandal. Visakhapatnam, Pin-531 019, Andhra Pradesh, India.

Pashamylaram

Reactor Volume -

375 / 1395 m3

Suven Pharmaceuticals Limited, Plot No’s.: 262 to 271, IDA Pashamylaram, Sangareddy District, Pin – 502307, Telangana, India.

Suryapet

Reactor Volume -

266 / 1395 m3

Suven Pharmaceuticals Limited, Dasaigudem Village, Suryapet (M), SuryapetDist. – 508 213, Telangana, INDIA.

Jeedimetla

Reactor Volume -

28 / 1395 m3

Suven Pharmaceuticals Limited, Plot No. 18, Phase-Ill IDA, Jeedimetla, Hyderabad – 500055, Medchal -Malkajgiri District, Telangana, INDIA

Shamshabad

Formulation Facility

Survey No. 99/1, Plot No-9A(1), Mamidipally Village, Balapur Mandal, Shamshabad, Rangareddy, Telangana 500108, India (IND)

Facilities
Infrastructure